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Abstract
Background: Many common disorders have multiple genetic components which convey increased
susceptibility. SNPs have been used to identify genetic components which are associated with a
disease. Unfortunately, many studies using these methods suffer from low reproducibility due to
lack of power.
Results: We present a set of programs which implement a novel method for searching for disease-
associated genes using prior information to select and order genes from publicly available databases
by their prior likelihood of association with the disease. These programs were used in a published
study of childhood-onset SLE which yielded novel associations with modest sample size.
Conclusion: Using prior information to decrease the size of the problem space to an amount
commensurate with available samples and resources while maintaining appropriate power enables
researchers to increase their likelihood of discovering reproducible associations.
Background
Many common disorders have genetic components which
convey increased susceptibility. While linkage and associ-
ation analyses have been quite successful in identifying
rare variants with high penetrance, such as in Hunting-
ton's disease [1] and some forms of cancer [2], the ability
of these approaches to detect common variants with more
modest effects (less penetrance) is limited. Frequent alle-
les with modest genetic effects play important roles in the
susceptibility to most diseases. For example, most autoim-
mune disorders involve multiple alleles of different genes
with individual low penetrance which also interact with
environmental factors to produce the final disease pheno-
type. Dissecting the disease phenotype into the individual
genes and associated alleles that are responsible is crucial
for understanding the mechanism of the disease and ulti-
mately developing treatment modalities [3].
To this end, many researchers have been using genome-
wide approaches to locate Single Nucleotide Polymor-
phisms (SNPs) that are in disequilibrium with a disease-
causing allele, or associated with a disease phenotype [3].
Unfortunately, the requirement to completely scan the
entire genome with sufficient SNP coverage required to
achieve an appropriate study-wide power as well as the
concomitant increase in number of subjects required to
overcome the multiple-testing effect makes this type of
study prohibitively expensive. Indeed, many association
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studies are under-powered, which leads to low reproduci-
bility, compounded additionally by publication bias [4-
7].
There are two general methods to reduce the number of
SNPs tested in a search for variants which convey suscep-
tibility. The first is to reduce the number of SNPs necessary
to cover the entire genome by maximizing the informa-
tion conveyed by each individual SNP. This process
involves the elimination of redundant SNPs whose state is
already determined with high probability by other SNPs
in the study [8,9]. The second method is to use prior avail-
able information to select genes and genomic regions
likely to be involved in a disease and testing the most
likely genes and regions in preference to the least likely.
While this approach does have advantages over a whole-
genome study, specifically in financial cost, time required
and a smaller number of subjects needed to assure reason-
able power, it does have disadvantages in that it does not
select candidate genes which are not associated with bio-
logical functions or genomic regions currently thought to
be related or linked to a disease.
In order to determine which genes or genomic regions are
likely to be associated with the disease, it is necessary to
connect genes and genomic areas with available literature
on the disease and disease-associated pathways. The
implementation we present here relies on experts to build
a list of keywords and genomic areas from the available
literature and expert knowledge coupled with publicly
available databases to connect keywords and genomic
areas to specific genes. An alternative using automated
information extraction techniques which do not rely on
expert knowledge is presented in the discussion. This
experimental design, where the genes (and consequently,
SNPs within those genes) are selected using prior availa-
ble information allows for the determination of the prior
probability that a particular gene is associated with a
disease.
Once specific genes have been selected, the SNPs used in
the study need to be selected. A popular class of methods
is the tagSNP methods, which attempt to reduce the
number of SNPs while maximizing the information that
each SNP represents by grouping SNPs that are in linkage
disequilibrium with each other and in the same phase (see
[8,9] for a comparison of different methods). The genes
suggested by our program and its associated method do
not necessarily require such powerful techniques, but dis-
carding redundant SNPs will be useful in maximizing
power while reducing cost. Beyond discarding non-
informative SNPs, special importance should be placed
on functional SNPs as they are more likely to actually rep-
resent the disease allele in question.
The method presented here uses a combination of auto-
mated and manual approaches to maximize the power of
a study using SNPs. The method has the following steps:
1. Use expert knowledge and literature to identify a set of
keywords (biological functions and genetic regions)
which have high prior probability of being associated
with the disease.
2. Use publicly available databases to select genes that ref-
erence the set of keywords.
3. Rank the identified genes based on their prior probabil-
ity of association using the selection results and expert
knowledge.
4. Choose an appropriate number of genes for SNP selec-
tion and association studies based on the number of cases
available, monetary, and time constraints of the study
while maintaining acceptable study-wide power.
5. Conduct study.
6. Analyze results, optionally using the prior probability
of association obtained during genetic selection.
Implementation
The application is separated into a series of separate
scripts, each of which has a specific function, and operate
in a specific order (see Figure 1).
Once a set of keywords (biological functions and genomic
locations judged to be associated or otherwise involved
with the disease) has been identified by expert knowledge
of the disease in question, publicly available databases
(currently NCBI, GeneCards, and Harvester are defaults,
Schematic of the gene selection process Figure 1
Schematic of the gene selection process. Flow chart of 
the separate methodology and the scripts which enact the 
methodology, as described in the introduction and imple-
mentation sections.BMC Bioinformatics 2008, 9:311 http://www.biomedcentral.com/1471-2105/9/311
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but Uniprot and Ensembl are also supported) are queried
in series with delays between each query as appropriate
for each database to avoid overloading them. Because
there is no well documented common interchange format
for these databases, the get_series of scripts download the
HTML (or XML) which the search requests generate and
save it. To avoid putting unreasonable demands on the
databases, the get_scripts limits the number of requests
they make per minute.
After all of the HTML (or XML) has been retrieved, the
next series of scripts (parse_) are run which use the
HTML::Parse (or XML::Parser::Expat) module to extract
the gene name, accession number for the reference
sequence, genomic location, alias(es), function(s), and
description.
These files are then combined into a single file by
combine_results that tracks what database and keyword
resulted in which genes. The aliases from all databases are
joined. Gene descriptions are retrieved from each data-
base; the longest description is retained in the final list.
For example, Harvester, when queried with "adhesion",
returns VCAM1 (amongst others). Harvester also returns
VCAM1 when queried with "inflammation". GeneCards
also returns VCAM1 for these two queries.
combine_results would then indicate that GeneCards
returned VCAM1 twice, Harvester returned VCAM1 twice,
and it was returned for "adhesion" and "inflammation".
At the same time three separate weighting procedures are
applied to order the genes. First, a simple approach,
dubbed "rzscore", simply counts the number of times that
a gene was returned by unique search terms, and orders
the results from most number of term matches to least.
The second, allows user-specified weights to be applied to
each keyword, and orders the results by the sum of the
weights of the corresponding keywords which returned a
result. The third method automatically weights the key-
words to avoid over-counting keywords which are entirely
subsets of other keywords. It does this by dividing the
number of results returned by a keyword by the sum of the
number of results returned by that keyword and any other
keyword, including itself.
To facilitate easier use of this collection of meta-search
utilities, a script which binds them all together has also
been provided, called function2gene, which takes a set of
keywords, an optional set of databases to query, and
returns the complete tabulated results to the specified
directory.
By using perl and existing modules (WWW::Mechanize,
HTML::TreeBuilder and XML::Parser) the actual number
of lines (and resulting implementational complexity) of
the codebase is greatly reduced, as custom code to deal
with form submission as well as HTML and XML parsing
did not need to be written. This approach also allows the
scripts to be slightly less dependent on the exact output
format of the sites which are searched. Splitting the
retrieval and parse stages also allows for extracting addi-
tional information from the search results by modifying
the parser and reparsing the results without waiting to
retrieve results from the remote databases again.
Results and discussion
The system described above was utilized to generate a list
of genes which were then used to select SNPs in a study of
childhood-onset Systemic Lupus Erythematosus (SLE).
SLE is a debilitating multi-system autoimmune disorder
affecting ≈ 0.1% of the North American population. An
initial search using a set of 31 keywords (consisting of bio-
logical functions and chromosomal regions) selected by
expert knowledge returned 6798 genes with various con-
tributions from the three databases used (Table 1). It is
important to note that the results obtained are tempo-
rally-sensitive; as databases are updated different sets of
genes will be returned. In every case a single database did
not retrieve all the genes found by other databases, dem-
onstrating the need to query multiple databases. The sub-
stantial contribution made by each database in
identifying the candidate genes demonstrates that each of
the databases is required to maximize the number of can-
didate genes discovered, though there are likely results
which are still not captured by the set of databases que-
ried. As new databases come into prominence,
Function2Gene can be extended to query them as well.
The top 1204 genes (of which 836 were returned by Gene-
Cards, 699 by Harvester, and 135 by NCBI) were used to
select 9412 SNPs. The number of genes to select was dic-
tated by the capacity of the chip (≈ 10,000 SNPs), and a
decision to have approximately ten SNPs per gene on
average. The choice of SNPs to genotype within the
selected genes was based on available information from
databases including the Human Haplotype Mapping
Project (HapMap) with priority given to SNPs with high
heterozygosity in two or more relevant ethnicities and to
SNPs representing amino acid coding variants. The
selected SNPs were then cross-checked against the accu-
mulated SNP validation test results available at our indus-
trial collaborator (ParAllele Biosciences), an active
participant of the International HapMap project.
Using the selected SNPs, 251 nuclear families consisting
of both parents and the affected child (full trios) were gen-
otyped. The analysis of the genotypes of the 251 trios
using Transmission Disequilibrium Test (TDT) followed
by False Discovery Rate (FDR) multi-test correction
yielded 9 noteworthy genes, that are associated with SLE
with FDR less than 0.5; two of these genes were highly sig-
nificant, with FDR less than 0.05 [10].BMC Bioinformatics 2008, 9:311 http://www.biomedcentral.com/1471-2105/9/311
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Using Bayesian methodologies, the impact of pre-existing
knowledge of a disease on the discovery of genes associ-
ated with the disease can be increased, as the posterior
probability of association with the disease can be modi-
fied in accordance with its prior probability as reported by
function2gene. The False Positive Report Probability
(FPRP) measure is one such method which uses the prior
probability of association, which can be calculated from
the results of the keyword-based gene selection, to modify
the posterior probability of association. Using Bayes' the-
orem  , FPRP determines the proba-
bility of the null hypothesis (no association) being true
given a test statistic greater than Zα (that is to say p ≤ α),
knowing power (1 - β), the prior probability of associa-
tion (π), and the probability of the measured data given
that the null hypothesis is true (p) [11]:
One method of calculating prior probability based on the
keyword based gene selection is to order the SNPs accord-
ing to number of times they were returned by different
keywords, taking into account the biological relevance of
the SNP, and then apply a continuous function such that
the higher ranked SNPs have a greater prior probability of
association than the lower ranked SNPs, and the sum of
the probability of association is the prior estimate of the
total number of SNPs in the search believed to be associ-
ated with the disease. An alternative method is to order
the SNPs in the same manner, and then place them in to
different groups, assigning the same prior probabilities to
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Table 1: Results of gene selection process
Keyword GeneCards Harvester NCBI Total Unique
12q24 355 (90) 217 (6) 276 (25) 391 (337)
16q12 108 (50) 34 (1) 65 (9) 118 (101)
1q23 251 (125) 94 (11) 135 (29) 295 (224)
1q25 144 (65) 50 (3) 94 (20) 167 (117)
1q31 96 (42) 32 (3) 58 (7) 106 (60)
1q41 69 (28) 23 (2) 54 (13) 85 (42)
1q42 212 (66) 107 (6) 153 (22) 241 (190)
2q35 107 (40) 39 (2) 75 (9) 120 (62)
2q36 92 (30) 50 (4) 53 (6) 104 (47)
2q37 217 (62) 97 (4) 156 (12) 233 (197)
4p15 100 (40) 40 (1) 68 (8) 110 (77)
4p16 219 (72) 114 (11) 165 (23) 257 (215)
6p11 19 (12) 6 (2) 9 (1) 23 (15)
6p12 114 (48) 44 (3) 82 (18) 136 (82)
6p21 749 (162) 321 (23) 597 (31) 809 (584)
adhesion 918 (428) 711 (221) - 1139 (575)
antigen 712 (298) 787 (373) - 1085 (0)
apoptosis 1013 (555) 682 (224) - 1237 (564)
chemokine 168 (95) 118 (45) - 213 (31)
chemotaxis 148 (62) 132 (46) - 194 (23)
coagulation 145 (73) 111 (39) - 184 (26)
complement 253 (155) 151 (53) - 404 (119)
cytokine 531 (256) 439 (164) - 695 (222)
immunity 132 (101) 125 (94) - 226 (26)
immunodeficiency 562 (485) 103 (26) - 588 (213)
inflammation 159 (103) 119 (63) - 222 (34)
phagocytosis 64 (36) 44 (16) - 80 (11)
Total Unique 5466 (1925) 3937 (1106) 2025 (204) 6798 (2403)
Number of genes returned for a subset of the keywords used in the example study [10] for each database (GeneCards, Harvester and NCBI). The 
genes returned by a specific keyword and only this database are in parenthesis. The Total Unique column gives the total number of unique genes for 
each keyword with unique genes returned only by this keyword in parenthesis. The Total Unique row gives the total number of unique genes for 
each database with genes returned only by this database in parenthesis. The intersection of the Total Unique row and the Total Unique column 
gives total number of unique genes with genes returned by only one database, and the number in parenthesis gives the number of genes returned by 
only one database and only one keyword. - indicates that a keyword was not used with a database. As some composite keywords used in the study 
[10] were omitted for clarity, the totals in this Table reflect the total number of genes retrieved, not the sums of the columns.BMC Bioinformatics 2008, 9:311 http://www.biomedcentral.com/1471-2105/9/311
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each SNP in a group while controlling the sum of the prior
probabilities assigned. For example, assuming 10,000
SNPs, 10 of which are believed to be associated, assign pri-
ors of π = 0.025 for the top 1%, 6.25 × 10-3 to the next top
4%, 1.25 × 10-3 to the next top 20%, and 3.33 × 10-4 to the
remaining 75%. In this manner the multiple testing effect
is controlled while maximizing the effect of the prior
available information. Applying FPRP [11] to the results
of the TDT test with a prior assumption of 8 associated
SNPs yielded 12 noteworthy genes, including all 9
obtained with the FDR corrections, and the same two sig-
nificant genes [10].
An existing web-based program which is functionally sim-
ilar to the methodology presented here is the Disease Can-
didate Gene search of SNPs3d. Using the keywords
chosen by SNPs3d for three diseases, diabetes, pancreatic
cancer, and Alzheimer disease, we have compared the
results obtained by SNPs3d and Function2Gene in Table
2. The majority of high ranking genes returned by SNPs3d
are also returned by Function2Gene, but Function2Gene
returns a far greater number of genes.
Future advancements of the approach presented here
could be made by the use of more powerful literature min-
ing techniques which would reduce (or even eliminate)
the need for expert information on the nature, pathology,
and biology of the disease to generate a list of keywords
and discard spurious results. Such approaches would also
reduce the reliance of this approach on the contents of
stewarded fields in the databases, enabling novel associa-
tions as well as incorrect associations to be discerned. For
example, Named Entity Recognition (NER) and Relation-
ship Extraction (RE) could be used in tandem to elucidate
connections between diseases and genes directly. NER
identifies biologically-relevant entities (like genes and
proteins) from literature using techniques such as hidden
Markov models and dictionaries. Once entities have been
identified, RE can identify the relationship and/or connec-
tion between entities using the proximity of entities (and
the re-occurrence of entities in close proximity), along
with rule base systems and full predicate/subject gram-
mars [12-14]. It would then be possible to walk the rela-
tionship tree, using the probabilities between each node
of the tree connecting specific genes and a disease (with
intervening genes, proteins, and biological pathways in
between), and then ordering the resultant genes by the
probability of their connection which should be directly
proportional to the prior probability of association.
Conclusion
The use of available prior information to decrease the size
of the problem space for gene identification in complex
polygenic disorders is an as yet underutilized technique.
The methodology and the programs presented here use
data mining techniques to retrieve from a few databases a
number of genes with high prior probability of being
associated with the disease. The program also allows to
order genes by relevance, thereby allowing the problem
space to be greatly reduced, increasing the power of the
study and thus increasing the likelihood of successfully
finding associated genes.
Availability and requirements
￿ Project name: Function2Gene
￿ Project homepage: http://rzlab.ucr.edu/function2gene
￿ Operating system(s): Platform independent
￿ Programming Language: Perl
￿ License: GNU GPL v2 or later at your option
Abbreviations
FDR: False Discovery Rate; FPRP: False Positive Report
Probability; NER: Named Entity Recognition; RE: Rela-
tionship Extraction; SLE: Systemic Lupus Erythematosus;
SNP: Single Nucleotide Polymorphism; TDT: Transmis-
sion Disequilibrium Test.
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